ABSTRACT

The research article evaluates the effectiveness of Mitomycin C (MMC) as an adjunctive therapy in endoscopic dacryocystorhinostomy (DCR) for the treatment of chronic obstruction in the nasolacrimal duct. The study included 80 patients divided into two groups of 40 patients each. 40 patients were treated with DCR alone and the other 40 patients received DCR supported with MMC (DCR + MMC group). Results were evaluated based on stoma patency and epiphora relief. The results demonstrated a higher success rate in the group that underwent DCR+MMC as compared to the DCR group. No postoperative complications were observed in either group. In conclusion, it was demonstrated that Mitomycin C application has a role in raising the success rate of endoscopic DCR.